Skip to main content
Home
  • The Legislative Assembly meets on 16/04/2024 (01:00 PM)
    Assembly sit 16/04/2024
  • The Legislative Council meets on 16/04/2024 (01:00 PM)
    Council sit 16/04/2024
  • The Public Administration meets on 08/04/2024 (10:00 AM)
    Committee meet 08/04/2024

Parliamentary Questions


Question On Notice No. 3 asked in the Legislative Council on 4 May 2021 by Hon Nick Goiran

Question Directed to the: Minister for Mental Health representing the Minister for Health
Parliament: 41 Session: 1


Question

(1) How many children and adolescents received treatment at the Perth Children's Hospital Gender Diversity Service in the 2016, 2017, 2018, 2019 and 2020 calendar years?
(2) What constitutes ‘treatment’ for the numbers provided in (1)?
(3) How many children and adolescents commenced stage one puberty blocker treatment at the Perth Children's Hospital Gender Diversity Service in the 2016, 2017, 2018, 2019, 2020 calendar years?
(4) How many children are currently receiving stage one puberty blocker treatment at the Perth Children's Hospital Gender Diversity Service?
(5) How many children commenced stage two cross sex hormone treatment at the Perth Children's Hospital Gender Diversity Service in the 2016, 2017, 2018, 2019, 2020 calendar years?
(6) How many children and adolescents are currently receiving stage two cross sex hormone treatment at the Perth Children's Hospital Gender Diversity Service?
(7) What was the age of the youngest child to receive treatment at the Perth Children’s Hospital in each of the years 2016, 2017, 2018, 2019 and 2020?
(8) What is the age of the youngest child who is currently receiving treatment at the Perth Children's Hospital Gender Diversity Service?

Answered on 1 June 2021

I am advised:

(1)

Year

Stage One

Stage Two

2016

14

7

2017

28

17

2018

47

21

2019

47

38

2020

49

47

 

(2) ‘Treatment’ is defined as those patients who are pubertal and who are treated with puberty suppression (“Stage One”) or estrogen or testosterone (“Stage Two”).

 

(3)

Year

Commenced Stage One

2016

14

2017

22

2018

35

2019

28

2020

25

 

(4)  44 currently receiving Stage One puberty blocker treatment.

 

(5)

Year

Commenced Stage Two

2016

6

2017

10

2018

15

2019

31

2020

29

 

(6) 43 currently receiving Stage Two cross sex hormone treatment.

 

(7)

Year

Stage One

Stage Two

2016

9 years 2 mths

15 years 2 mths

2017

12 years 8 mths

16 years 2 mths

2018

10 years 8 mths

15 years 9 mths

2019

10 years 10 mths

15 years 10 mths

2020

10 years 11 mths

15 years 1 mth

 

(8) Youngest patient currently receiving puberty suppression (Stage One): 11 years 4 months.

Youngest patient currently receiving hormone therapy (Stage Two): 15 years 5 months.